Naseer Maliyakkal

Naseer Maliyakkal

Auto-generated profile, based on publicly available information

Naseer Maliyakkal

Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Bulletin of Materials Science
Verified
Journal Article
Closed access
PDF file
RARanjith K Averineni
Ranjith K Averineni
GSGopal V Shavi
Gopal V Shavi
AGAravind K Gurram
Aravind K Gurram
PDPraful B Deshpande
Praful B Deshpande
KAKarthik Arumugam
Karthik Arumugam
UNUdupa Nayanabhirama
Udupa Nayanabhirama

1 May 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
RERajasegaran Elumalai
Rajasegaran Elumalai
SPShilpa Patil
Shilpa Patil
NMNaseer Maliyakkal
Naseer Maliyakkal
ARAnnapoorni Rangarajan
Annapoorni Rangarajan
PKPaturu Kondaiah
Paturu Kondaiah
ARAshok M. Raichur
Ashok M. Raichur

4 May 2012 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
AIArun M. Isloor
Arun M. Isloor
DSDhanya Sunil
Dhanya Sunil
PSPrakash Shetty
Prakash Shetty
SMShridhar Malladi
Shridhar Malladi
KPK. Sreedhara Ranganath Pai
K. Sreedhara Ranganath Pai
NMNaseer Maliyakkl
Naseer Maliyakkl

8 December 2011 in Nanotechnology
Verified
Journal Article
Closed access
PCParvathy R Chandran
Parvathy R Chandran
MNM Naseer
M Naseer
NUN Udupa
N Udupa
NSN Sandhyarani
N Sandhyarani
Size and shape controlled synthesis remains a major bottleneck in the research on nanoparticles even after the development of different methods for their preparation. By tuning the size and shape of a nanoparticle, the intrinsic properties of the nanoparticle can be controlled leading tremendous potential applications in different fields of science and technology. We describe a facile route for the one pot synthesis of gold nanoparticles in water using monosodium glutamate as the reducing and stabilizing agent in the absence of seed particles. The particle diameter can be easily controlled by varying the pH of the reaction medium. Nanoparticles were characterized using scanning electron microscopy, UV-vis absorption spectroscopy, cyclic voltammetry, and dynamic light scattering. Zeta potential measurements were made to compare the stability of the different nanoparticles. The results suggest that lower pH favours a nucleation rate giving rise to smaller particles and higher pH favours a growth rate leading to the formation of larger particles. The synthesized nanoparticles are found to be stable and biocompatible. The nanoparticles synthesized at high pH exhibited a good electrocatalytic activity towards oxidation of nicotinamide adenine dinucleotide (NADH).

1 September 2013 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
AJAlex Joseph
Alex Joseph
CSChaitanyakumar S. Shah
Chaitanyakumar S. Shah
SSSharad Kumar Suthar
Sharad Kumar Suthar
AAAngel Treasa Alex
Angel Treasa Alex
NMNaseer Maliyakkal
Naseer Maliyakkal
JMJessy Elizabeth Mathew
Jessy Elizabeth Mathew
A series of novel 5-alkyl/aryl thiadiazole substituted thiazolidin-4-ones were synthesized by a two-step process. In the first step, 5-alkyl/aryl substituted 2-aminothiadiazoles were synthesized, which on reaction with substituted aromatic aldehydes and thioglycolic acid in the presence of dicyclohexylcarbodiimide afforded thiazolidin- 4-ones. All the compounds were synthesized in fairly good yields and their structures were confirmed by spectral and physical data. The title compounds were screened for in vitro anti-proliferative activity on human breast adenocarcinoma cells (MCF-7) by MTT assay. Most of the derivatives showed an IC50 less than 150 μmol L-1. Among the compounds tested, 2-(2-nitrophenyl)- 3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiazolidin-4-one (3f), 2-(3-fluorophenyl)-3-(5-methyl-1,3,4-thiadiazol-2- -yl)-thiazolidin-4-one (3b), and 2-(4-chlorophenyl)-3- -(5-methyl-1,3,4-thiadiazol-2-yl)-thiazolidin-4-one (3c) were found to be the most active derivatives with IC50 values of 46.34, 66.84, and 60.71 μmol L-1, respectively. Antioxidant studies of all the synthesized compounds were carried out by diphenylpicrylhydrazyl (DPPH) assay. Among the compounds tested, 2-phenyl-3-(5-styryl- -1,3,4-thiadiazol-2-yl)-thiazolidin-4-one (3s) elicited superior antioxidant activity with IC50 of 161.93 μmol L-1.

1 November 2015 in Life Sciences
Verified
Journal Article
Closed access
GSGopal Venkatesh Shavi
Gopal Venkatesh Shavi
UNUsha Y Nayak
Usha Y Nayak
NMNaseer Maliyakkal
Naseer Maliyakkal
PDPraful Balavant Deshpande
Praful Balavant Deshpande
RRRamesh Raghavendra
Ramesh Raghavendra
BSB. Shrawan
B. Shrawan